Featured articles from the journal CHEST®, May 2023

Published monthly, the journal CHEST^® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical care and sleep medicine and related disciplines. Journal topics include asthma, chest infections, COPD, critical care, diffuse lung disease, education and clinical practice, pulmonary vascular disease, sleep, thoracic oncology and the humanities.

The May issue of the CHEST journal contains 50 articles, including clinically relevant research, reviews, case series, commentary and more. Each month, the journal also offers complementary web and multimedia resources, including visual abstracts, to expand the reach of its most interesting, timely and relevant research.

“To raise awareness for cystic fibrosis in May, in addition to the research included in the latest issue, I recommend visiting the journal’s Adult Cystic Fibrosis Series,” says Editor in Chief of the journal, Peter Mazzone, MD, MPH, FCCP. “One of the four available journal CHESTSpecial Series, the grouping around adult cystic fibrosis examines a once fatal childhood condition (more than 90% mortality rate in the first year of life) that is now a disease across the age spectrum, including adulthood.”

Also included in the current issue of the journal CHEST:

Asthma

“A Total Diet Replacement Weight Management Program for Difficult-to-Treat Asthma Associated With Obesity” shows that over 16 weeks, the Counterweight-Plus Program resulted in clinically relevant improvements in both asthma control and quality-of-life indexes, with substantial weight loss, as compared with usual care. View the visual abstract for this research.

Critical Care

Looking at targeted temperature management in the ICU, “Differential Effect of Targeted Temperature Management Between 32 °C and 36 °C Following Cardiac Arrest According to Initial Severity of Illness” finds 32 °C to 36 °C was significantly associated with better outcomes in patients with low and high severity Cardiac Arrest Hospital Prognosis score at ICU admission. View the visual abstract for this research.

Education and Clinical Practice

A pilot randomized, controlled trial, “Nebulized vs IV Tranexamic Acid for Hemoptysis,” suggests nebulized tranexamic acid may be more efficacious than IV tranexamic acid in reducing the amount of hemoptysis and the need for interventional procedures in the ED. View the visual abstract for this research. Listen to a podcast of the experts discussing their findings.

Thoracic Oncology

Assessing the relationship between pulmonary nodules (PNs) and lung cancer in the Medicare population, “Pulmonary Nodules, Lung Cancer Screening, and Lung Cancer in the Medicare Population” suggests PNs represent a relatively common presentation of potentially curable lung cancer. Listen to a podcast of the experts discussing their findings.

---

Notes 

To view the entire May issue of CHEST journal (volume 163, issue 5), published by Elsevier, visit journal.chestnet.org and follow @journal_CHEST on Twitter for the latest journal news.

Full text of these articles and interviews with the authors are available to credentialed journalists upon request; contact Laura DiMasi, Senior Specialist, Communications and Public Relations, American College of Chest Physicians (CHEST), at media@chestnet.org.

About the journal CHEST^®

The journal CHEST, the official publication of the American College of Chest Physicians®, features the best in peer-reviewed, cutting-edge original research in the multidisciplinary specialties of chest medicine: pulmonary, critical care, and sleep medicine; thoracic surgery; cardiorespiratory interactions; and related disciplines. Published since 1935, it is home to the highly regarded clinical practice guidelines and consensus statements. Access the journal CHEST online at journal.chestnet.org.

About the American College of Chest Physicians

The American College of Chest Physicians^® (CHEST) is the global leader in the prevention, diagnosis, and treatment of chest diseases. Its mission is to champion advanced clinical practice, education, communication, and research in chest medicine. It serves as an essential connection to clinical knowledge and resources for its 19,000+ members from around the world who provide patient care in pulmonary, critical care, and sleep medicine. For information about the American College of Chest Physicians, and its flagship journal CHEST^®, visit chestnet.org.

About Elsevier
As a global leader in information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making for customers across the global research and health ecosystems.

In everything we publish, we uphold the highest standards of quality and integrity. We bring that same rigor to our information analytics solutions for researchers, health professionals, institutions and funders.

Elsevier employs 8,700 people worldwide. We have supported the work of our research and health partners for more than 140 years. Growing from our roots in publishing, we offer knowledge and valuable analytics that help our users make breakthroughs and drive societal progress. Digital solutions such as ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath support strategic research management, R&D performance, clinical decision support, and health education. Researchers and healthcare professionals rely on over 2,800 digitized journals, including The Lancet and Cell; our 46,000+ eBook titles; and our iconic reference works, such as Gray’s Anatomy. With the Elsevier Foundation and our external Inclusion & Diversity Advisory Board, we work in partnership with diverse stakeholders to advance inclusion and diversity in science, research and healthcare in developing countries and around the world.

Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers.

###

IMAGE CAPTION:

Is There an Association Between Targeted Temperature Management (TTM) of 32 °C to 36 °C and Neurological Outcomes? (Credit: Jean Baptiste Lascarrou, MD, PhD, et al., CHEST, May 2023, https://doi.org/10.1016/j.chest.2022.10.023